天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Analytical Chemistry>Standard>Pharmaceutical Impurity Reference Standards>N-Methyl Loratadine
N-Methyl Loratadine
  • N-Methyl Loratadine

N-Methyl Loratadine

Price $15
Package 1G
Min. Order: 10G
Supply Ability: 10 tons
Update Time: 2023-09-15

Product Details

Product Name: N-Methyl Loratadine CAS No.: 38092-89-6
EC-No.: 641-012-1 Min. Order: 10G
Purity: 99.9% Supply Ability: 10 tons
Release date: 2023/09/15
  • Common Name: N-Methyl Loratadine

  • CAS: 38092-89-6

  • MF: C20H21ClN2

  • MW: 324.85

  • EINECS: 641-012-1

  • Form: Neat

  • Color: White 


Port: Shanghai, China


Production Capacity: 20t Per Month


Payment: L/C, T/T, D/P, Western Union, Paypal, Money Gram, BTC


Customized: Customized


Certification: GMP, HSE, ISO 9001, USP, BP


Package: Customized


Brand: LIHE



Related Products

Article illustration

Hot Selling Products


  • 79099-07-3   1-Boc-4-Piperidone

  • 40064-34-4    4-Piperidone Hydrochloride Monohydrate

  • 288573-56-8    1-BOC-4-(4-FLUORO-PHENYLAMINO)-PIPERIDINE

  • 1451-82-7          2-Bromo-4'-methylpropiophenone

  • 5413-05-8          Ethyl 2-phenylacetoacetate

  • 16595-80-5        Levamisole hydrochloride

  • 20320-59-6        Diethyl(phenylacetyl)malonate

  • 28578-16-7        2-Oxiranecarboxylicacid, 3-(1,3-benzodioxol-5-yl)-2-Methyl-, ethyl ester

  • 136-47-0            Tetracaine HCl

  • 102-97-6            N-Isopropylbenzylamine

  • 94-09-7              Benzocaine

  • 443998-65-0    1-BOC-4-(4-BROMO-PHENYLAMINO)-PIPERIDINE


Contact us

Wickr Me: sakurazhu
Whatsapp/ Telegram: +86 18186183733
Skype/E-mail: sakura@lihepharma.com
Wechat: 18186183733

Company Profile Introduction

Lihe Pharm(Wuhan) Technology Co., Ltd. is a company specializing in the production and management of pharmaceutical intermediates and chemical import and export trade. Our company has long-term cooperation with Wuhan Research Institute and various universities and has a complete scientific research system and quality certification. system. The company has two pilot production bases, which are mainly engaged in the production of APIs, pharmaceutical intermediates, and the customization of special chemicals. After several years of operation, the products are sold at home and abroad and won numerous praises. In the future operations, we will continue to adhere to the principles of cooperation, keeping promises, sincerity, equality, mutual benefit and mutual benefit, and provide you with high-quality services. We sincerely welcome friends from all walks of life at home and abroad to visit and guide and cooperate sincerely.

Article illustration



Company Profile Introduction

Lihe Pharmaceutical Technology (Wuhan) Co., Ltd. is a pharmaceutical company integrating product development, production and chemical intermediates, specializing in the research, development, production and export of organic intermediates, pharmaceutical intermediates, chemical solvents and pesticides

You may like

Recommended supplier

Product name Price   Suppliers Update time
$10.00/1kg
VIP1Y
Wuhan Xinhao Biotechnology Co., Ltd
2024-03-11
$0.00/1kg
VIP2Y
Hebei Kingfiner Technology Development Co.Ltd
2023-12-06
$35000.00/1kg
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-06-01
$10.00/1kg
Henan Bao Enluo International TradeCo.,LTD
2023-05-16
$10.00/1KG
Qiuxian Baitai New Material Co., LTD
2021-12-20
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
$150.00/1KG
VIP6Y
Anhui Dexinjia Biopharm Co., Ltd
2021-01-13
$1.00/1KG
VIP7Y
Career Henan Chemical Co
2019-05-24
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-09
$0.00/1KG
Qiuxian Baitai New Material Co., LTD
2021-03-12
  • Since: 2022-04-18
  • Address: C018, No. 5, Floor 0615, Building 06, Building 06, Engineering Design Headquarters, Unit 3, Optics V
INQUIRY